Cerner is leveraging its latest acquisition of Kantar Well being to create a brand new enterprise unit focusing on firms conducting scientific trials, the corporate introduced Tuesday.
Dubbed Enviza, the brand new division will promote knowledge and analysis companies to facilitate scientific analysis carried out by life sciences companies. The unit will convey collectively Cerner’s knowledge enterprise with life sciences experience from Kantar Well being, which Cerner bought for $375 million by way of a deal that closed in April.
Enviza’s prospects primarily shall be life sciences firms and healthcare suppliers, stated Mike Kelly, world head of Enviza and former president and chief working officer of Kantar Well being. Suppliers that take part in Cerner’s Studying Well being Community can entry the digital well being information database and analytics instruments without charge. Firms creating new medicine and different therapies will present most of Enviza’s income, Kelly stated.
“Life sciences is keenly to have entry to the real-world knowledge,” Kelly stated. Life sciences firms using Enviza’s knowledge and companies will be capable to pace new therapies via the scientific and regulatory processes, he stated.
Enviza will promote entry to de-identified affected person data from EHRs and provide analysis companies to pharmaceutical and biotechnology firms. The brand new division is about as much as assist shoppers accumulate related knowledge, arrange trials, and submit security and efficacy findings to regulators.
Cerner’s Studying Well being Community is the repository for anonymized affected person information collected from 76 collaborating well being techniques. Enviza shoppers will be capable to use these knowledge to find sufferers who could also be applicable for scientific trials. Enviza will then give Cerner’s supplier prospects the choice to contact sufferers and invite them to take part in analysis research.
Digital well being information distributors equivalent to Cerner have sought to diversify their companies past promoting data expertise techniques by providing instruments and companies to assist suppliers and life sciences firms make the most of affected person knowledge for his or her operations.
Cerner has identified “data-as-a-service” as a development alternative. Previous to creating Enviza, the corporate put this into motion by creating the Studying Well being Community and investing in Elligo Health Research, a startup targeted on scientific trials.
“Cerner is certainly taking a look at monetizing the information sitting in its EHR platform,” stated Paddy Padmanabhan, CEO of Damo Consulting. “It is a large frontier within the unlocking of affected person knowledge.”
Final yr, Epic Programs launched Cosmos, a database of de-identified EHR knowledge collected within the Epic Well being Analysis Community. Allscripts’ Veradigm payer and life sciences division additionally sells analytics instruments to suppliers and de-identified affected person knowledge for biopharma researchers.
Healthcare suppliers have made forays into comparable strains of enterprise that compile and promote affected person knowledge, as effectively. Ventures equivalent to hospital-backed Truveta have raked in millions of dollars in investments.
Cerner reported $1.5 billion in second-quarter revenue in July, up 9.5% from $1.3 billion from the year-ago interval, which the corporate recognized because the quarter most affected by the COVID-19 pandemic. Cerner’s working earnings for the second quarter of 2021 have been down 66% to $49.6 million, the corporate reported. Cerner is because of announce its third-quarter financials on Friday.